There may be light at the end of the tunnel with three vaccines on the cusp of getting regulatory approval.

However, the U.K Government has approved the Pfizer/BioNTech vaccine so quickly.

How did the British government approve the Pfizer/BioNTech vaccine so quickly, and should people be worried? 

That’s the question that is being asked after Matt Hancock and Jacob Rees-Mogg falsely claimed that we were only able to expedite the use of the vaccine thanks to Brexit (we are still, as far as the operation of our laws, institutions and businesses concerned, EU members until the transition period ends, and we have temporarily approved the vaccine under measures available to all EU states). 

It’s a claim that neither Boris Johnson last night nor Gavin Williamson this morning were willing to support, with each finding different ways to avoid the question.

Both the U.S. vaccines are being sold at a profit whereas the Astra Zeneca/Oxford vaccine is being sold at cost (about £5).

My questions are as follows: Do any politicians making decisions on these vaccines, have shares in the companies? Why the indecent haste to approve a vaccine which has to be kept at -70 degrees which makes transportation and storage difficult whereas the Astra/Zeneca/Oxford vaccine needs no special storage.

Whenever politicians rush, I get suspicious. I prefer to wait for the Astra Zeneca/ Oxford vaccine.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s